Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-184,000
Closed -$10.6M 222
2015
Q1
$10.6M Hold
184,000
0.02% 126
2014
Q4
$9.83M Sell
184,000
-389,074
-68% -$21.8M 0.02% 136
2014
Q3
$32.9M Sell
573,074
-208,236
-27% -$12.8M 0.09% 101
2014
Q2
$52.2M Sell
781,310
-32,700
-4% -$2.21M 0.24% 91
2014
Q1
$54.4M Buy
814,010
+118,888
+17% +$8.04M 0.25% 88
2013
Q4
$46.4M Sell
695,122
-38,048
-5% -$2.47M 0.22% 93
2013
Q3
$46M Buy
733,170
+121,204
+20% +$7.8M 0.23% 90
2013
Q2
$38.2M Buy
+611,966
New +$38.8M 0.2% 93

Other funds holding GSK

General Electric's GSK Position: Q2 2015 in Review

General Electric sold out of GSK (GSK) in Q2 2015, closing a stake of 184,000 shares — an estimated $10.6M sold.

General Electric first reported a position in GSK in Q2 2013 and held it in 8 quarters. The position peaked at $54.4M in Q1 2014. 721 funds tracked by Wall St. Rank hold GSK as of Q2 2015.

  • General Electric reported no remaining GSK position as of Q2 2015 after selling out during the quarter.
  • General Electric sold 184,000 GSK shares in Q2 2015, an estimated $10.6M.
  • General Electric first reported a position in GSK in Q2 2013 and held it in 8 quarters.
  • General Electric's GSK position peaked at $54.4M in Q1 2014.
  • 721 funds tracked by Wall St. Rank held GSK as of Q2 2015.

Based on General Electric's 13F filing for Q2 2015, filed 13 Aug 2015.